Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00253084 · ClinicalTrials.gov registry record · Phase 2

Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease

A Phase 2 study of Parkinson's Disease, sponsored by Impax Laboratories.

Completed
Registry status
Phase 2
Development phase
12
Enrollment target
2
Study locations

NCT00253084 is a Phase 2 study of Parkinson's Disease that has completed, run by Impax Laboratories. The registered enrollment target is 12 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00253084, a Phase 2 study of Parkinson's Disease, has completed, sponsored by Impax Laboratories.

COMPLETED
Registry status
Phase 2
Development phase
12 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare the clinical efficacy of IPX054 to immediate-release carbidopa-levodopa in subjects with Parkinson's disease.

Conditions Studied

Parkinson's Disease

Interventions

  • DRUG IPX054 200 mg
  • DRUG CD-LD IR
  • DRUG IPX054 Placebo
  • DRUG CD-LD IR Placebo

Study Locations (2)

Illinois

  • Site 1 - Chicago

South Carolina

  • Site 2 - Charleston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2005-11
Est. Completion 2007-12
Phase Phase 2

Sponsor

Impax Laboratories

19 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00253084

The ClinicalTrials.gov registry entry for NCT00253084 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (98% lower). The listed sponsor is Impax Laboratories, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 4 interventions - of which IPX054 200 mg is the first listed.

NCT00253084 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, South Carolina.

Frequently Asked Questions

What is clinical trial NCT00253084 about?

NCT00253084 is a clinical study titled "Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease". The purpose of this study is to compare the clinical efficacy of IPX054 to immediate-release carbidopa-levodopa in subjects with Parkinson's disease.

What is the current status of trial NCT00253084?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2005-11. Estimated completion is 2007-12.

What conditions does trial NCT00253084 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT00253084?

The interventions under investigation include: IPX054 200 mg (DRUG), CD-LD IR (DRUG), IPX054 Placebo (DRUG), CD-LD IR Placebo (DRUG).

Who is sponsoring clinical trial NCT00253084?

This trial is sponsored by Impax Laboratories, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00253084 being conducted?

This trial has 2 study locations across Illinois, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.